An AIM-listed manufacturer, Beximco Pharma, which is also a subsidiary of Salman F Rahman’s Beximco Group, recently exported its blood drug Nadolol to the US market — a move towards expanding the pharmacy exports from Bangladesh. With an aim to enhance human health and the overall well-being of society, Beximco Pharma continues to offer contemporary […]
